首页> 外文期刊>Therapeutic innovation & regulatory science. >Analysis of the Current Situation of Antibiotics Use in China: A Hospital-Based Perspective
【24h】

Analysis of the Current Situation of Antibiotics Use in China: A Hospital-Based Perspective

机译:基于医院视角的中国抗生素使用现状分析

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To investigate the present situation of antibiotics use in selected hospitals in China according to 2 indicators: hospital-based market sales and frequency of usage; based on this information, to assess the government's containment policies toward antibiotics overuse. Methods: Marketing and clinical usage data of antibiotics in 420 selected hospitals from 21 major cities and 1 district in China during 2008-2011 were collected and analyzed. Usage frequency was measured by the defined daily dose (DDD) analytic approaches recommended by World Health Organization (WHO), and the growth rate of DDDs per patient was compared for 3 categories of antibiotics: nonlimited (first line), limited (second line), and specially controlled (third line). Results: During the period studied, an obvious slowdown was observed in both sales value and the growth of sales volume for the 3 categories. With respect to frequency, both limited-level and specially controlled level antibiotics with high cost and low safety and effectiveness showed an evident decline in the growth rate of DDDs per patient (P < .05). However, no significant decline was found for nonlimited antibiotics (P > .05). Conclusion: The Chinese government's containment policies toward antibiotics overuse are beginning to take effect, and antibiotics usage has become more measured in major cities. However, China still has a long way to go before it can win the battle against antibiotics overuse and drug resistance.
机译:目的:根据医院市场销售情况和使用频率;从以下两个指标出发,调查我国部分医院的抗生素使用现状。根据这些信息,评估政府对抗生素过度使用的遏制政策。方法:收集和分析2008-2011年中国21个主要城市和1个地区的420家选定医院的抗生素营销和临床使用数据。使用频率通过世界卫生组织(WHO)推荐的每日定义剂量(DDD)分析方法进行测量,并且比较了三种类型的抗生素每位患者DDDs的增长率:非限制(第一行),有限(第二行) ,并进行特殊控制(第三行)。结果:在研究期间,这三个类别的销售价值和销量增长均出现了明显的放缓。就频率而言,成本高,安全性和有效性低的限量和特殊控制水平的抗生素均显示出每位患者DDDs的增长率显着下降(P <.05)。然而,非限制性抗生素未发现显着下降(P> .05)。结论:中国政府对过度使用抗生素的遏制政策开始生效,在主要城市,抗生素的使用已变得更加可衡量。但是,中国要赢得与抗生素过度使用和耐药性作斗争的斗争,还有很长的路要走。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号